Stay in touch about special discounts, nutrition tips and additional education
Li X, Staszewski L, Xu H, Durick K, Zoller M, Adler E
Safety Considerations and Reporting Suspected Side Effects The most common adverse effects are gastrointestinal, including nausea, vomiting, and diarrhoea, particularly during dose escalation
By 2026, the landscape includes selective GLP-1 receptor agonists, dual GLP-1/GIP receptor co-agonists, triple receptor agonists targeting GLP-1/GIP/glucagon receptors simultaneously, and the first non-peptide oral small-molecule GLP-1 agonist
Physicians and patients should remain vigilant for emerging or persistent issues as additional data arrives
They increase everyone to the maximum dose regardless of body size, sensitivity, or how much weight loss is actually needed